BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26362275)

  • 1. Fibrinolytic Actinokinase--A Short Review.
    Dhamodharan D; Devi CS; Mohanasrinivasan V; Naine SJ
    Cardiovasc Hematol Agents Med Chem; 2015; 13(2):78-81. PubMed ID: 26362275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of thrombolytic, fibrinolytic, and fibrinogenolytic properties of tissue plasminogen activator, streptokinase, single-chain urokinase, high molecular weight and low molecular weight urokinase in human plasma in vitro.
    Samama M; Nguyen G; Desnoyers P; Lourenco DM; Fretault J; Horellou MH; Conard J; Szwarcer E; Verdy E; Vahanian A
    Fundam Clin Pharmacol; 1988; 2(6):509-23. PubMed ID: 3149257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and expression of an actinokinase gene from a thermophilic Streptomyces in Escherechia coli.
    Chitte RR; Dey S
    Indian J Exp Biol; 2001 May; 39(5):410-5. PubMed ID: 11510122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolytic versus fibrinogenolytic activity of rt-PA and streptokinase in patients with acute myocardial infarction.
    Prisco D; Bonechi F; Scarti L; Tramontana M; Abbate R; Gensini GF
    Angiology; 1990 Aug; 41(8):616-20. PubMed ID: 2117862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haematological effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study.
    Monassier JP; Hanssen M
    Drugs; 1987; 33 Suppl 3():247-52. PubMed ID: 2445540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapy.
    Smith RA; Dupe RJ; English PD; Green J
    Nature; 1981 Apr; 290(5806):505-8. PubMed ID: 7219537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical comparison of intermittent streptokinase and intermittent streptokinase plasminogen therapy.
    Barlow GH; Kakkar VV; Bentley PG; Chan PS; Jones NA; Mistry FD
    Thromb Res; 1979; 15(1-2):135-42. PubMed ID: 483271
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential effects of staphylokinase, streptokinase and tissue-type plasminogen activator on the lysis of retracted human plasma clots and fibrinolytic plasma parameters in vitro.
    Hauptmann J; Glusa E
    Blood Coagul Fibrinolysis; 1995 Sep; 6(6):579-83. PubMed ID: 7578902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization, mechanism of anticoagulant action, and assessment of therapeutic potential of a fibrinolytic serine protease (Brevithrombolase) purified from Brevibacillus brevis strain FF02B.
    Majumdar S; Sarmah B; Gogoi D; Banerjee S; Ghosh SS; Banerjee S; Chattopadhyay P; Mukherjee AK
    Biochimie; 2014 Aug; 103():50-60. PubMed ID: 24735708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The systemic fibrinolytic effect of low-dose intraarterial streptokinase: observations in 12 patients. Work in progress.
    Rubenfire M; Blevins RD; Cascade PN; Maltzman JB; Goldberg MJ
    Radiology; 1984 Jul; 152(1):41-3. PubMed ID: 6729136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R; Fears R; Smith RA
    Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity Regulation by Fibrinogen and Fibrin of Streptokinase from Streptococcus Pyogenes.
    Huish S; Thelwell C; Longstaff C
    PLoS One; 2017; 12(1):e0170936. PubMed ID: 28125743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physiology of hemostasis. II. Fibrinolysis].
    Sultan Y; Caen J; Allain JP; Meyer D
    Pathol Biol (Paris); 1969 May; 17(9):529-34. PubMed ID: 4240805
    [No Abstract]   [Full Text] [Related]  

  • 14. [Plasmin formation in a fibrin network].
    Kotschy M; Knapik M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(2):167-73. PubMed ID: 4106005
    [No Abstract]   [Full Text] [Related]  

  • 15. Streptokinase--a clinically useful thrombolytic agent.
    Banerjee A; Chisti Y; Banerjee UC
    Biotechnol Adv; 2004 Feb; 22(4):287-307. PubMed ID: 14697452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the interaction of group A streptococci with fibrinogen, streptokinase and plasminogen.
    Wang H; Lottenberg R; Boyle MD
    Microb Pathog; 1995 Mar; 18(3):153-66. PubMed ID: 7565010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The formation of a fibrinogen-activator complex by the action of streptokinase.
    Chesterman CN; Cederholm-Williams SA; Allington MJ; Sharp AA
    Thromb Res; 1977 Mar; 10(3):421-30. PubMed ID: 854878
    [No Abstract]   [Full Text] [Related]  

  • 18. [A comparative study of fibrinogenolysis of adult and cord vein fibrinogen (author's transl)].
    Hafter R; Wallenstätter R; Graeff H
    Hoppe Seylers Z Physiol Chem; 1981 Feb; 362(2):175-8. PubMed ID: 6452398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic effects of BRL 26921 during thrombolytic treatment of acute myocardial infarction.
    Hoffmann JJ; Van Rey FJ; Bonnier JJ
    Thromb Res; 1985 Mar; 37(5):567-72. PubMed ID: 3920779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fibrinolytic and thrombolytic properties of thiol-dependent serine proteinase from Thermoactinomyces vulgaris in vitro].
    Rudenskaia GN; Liutova LV; Andreenko GV; Karabasova MA; Tsaplina IA
    Prikl Biokhim Mikrobiol; 1987; 23(6):754-61. PubMed ID: 3481858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.